VISONE, Rosa
 Distribuzione geografica
Continente #
EU - Europa 1.706
NA - Nord America 1.677
AS - Asia 577
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 3.967
Nazione #
US - Stati Uniti d'America 1.676
IT - Italia 507
CN - Cina 273
IE - Irlanda 268
UA - Ucraina 255
TR - Turchia 205
SE - Svezia 168
GB - Regno Unito 165
FR - Francia 131
DE - Germania 115
IN - India 67
FI - Finlandia 45
BE - Belgio 23
VN - Vietnam 18
GR - Grecia 6
AT - Austria 4
PL - Polonia 4
SG - Singapore 4
HK - Hong Kong 3
IR - Iran 3
RO - Romania 3
RU - Federazione Russa 3
BR - Brasile 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
KR - Corea 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CA - Canada 1
CL - Cile 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JP - Giappone 1
LI - Liechtenstein 1
MD - Moldavia 1
NG - Nigeria 1
PT - Portogallo 1
Totale 3.967
Città #
Chandler 349
Jacksonville 304
Dublin 266
Chieti 203
Princeton 124
Southend 124
Dearborn 122
Izmir 111
Ann Arbor 107
Ashburn 75
Nanjing 67
Wilmington 58
Beijing 55
Cambridge 45
Altamura 26
Boardman 26
Woodbridge 23
Nanchang 21
Washington 20
Brussels 19
Montesilvano Marina 19
Dong Ket 18
Rome 18
Jiaxing 16
New York 15
Hebei 14
Shenyang 14
Carini 12
Kunming 11
Los Angeles 11
Jinan 10
Tianjin 9
Collecorvino 8
Hefei 8
L'aquila 8
Leawood 8
Orsogna 8
Changsha 6
Houston 6
Pescara 6
Teramo 6
Grevenbroich 5
Ningbo 5
Seattle 5
Augusta 4
Changchun 4
Nieuwrode 4
Norwalk 4
Orange 4
Redwood City 4
Vienna 4
Zhengzhou 4
Ardabil 3
Auburn Hills 3
Columbus 3
Edinburgh 3
Frankfurt am Main 3
Guangzhou 3
Hangzhou 3
Helsinki 3
Kraków 3
Lonigo 3
Mazara del Vallo 3
Mumbai 3
San Mateo 3
San Vito Chietino 3
Tappahannock 3
Altino 2
Antalya 2
Chengdu 2
Citta Sant'angelo 2
Fairfield 2
Fuzhou 2
Kyiv 2
Latina 2
L’Aquila 2
Montottone 2
Munich 2
Naples 2
Ortona 2
Redmond 2
Shanghai 2
Sheffield 2
Simi Valley 2
Singapore 2
Siracusa 2
Spoltore 2
São Paulo 2
Taizhou 2
Tyresö 2
Vasto 2
Akron 1
Andover 1
Anyang-si 1
Arnsberg 1
Baotou 1
Barletta 1
Basciano 1
Bergamo 1
Bologna 1
Totale 2.525
Nome #
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib 165
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 157
Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation 108
A developmental perspective on paragangliar tumorigenesis 104
A POSSIBLE ROLE OF A CMV-LIKE VIRUS IN HEAD AND NECK PARAGANGLIOMA PATHOGENESIS 103
Possible role of a CMV-like virus in paragangliomas 99
Epigenetics and microRNAs in cancer 94
Reprogramming of miRNA networks in cancer and leukemia. 93
MiR-181b in Chronic Lymphocytic Leukemia B Cells Is Regulated By Cellular Interaction with CD4+ T Cells and Increases the CTL Toxicity Versus the Leukemic Clone 91
Hsa-miR-200 and hsa-miR34 miRNA family members target cellular and viral genes regulating HCMV infection in head and neck paraganglioma 90
A developmental model of paragangliar tumorigenesis highlights therapeutic targets 87
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 84
Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells 83
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 81
Oncogenic role of miR-483-3p at the IGF2/483 locus. 80
Impact of BCR Stimulation on Mir-181b in Chronic Lymphocityc Leukemia 77
Hnrnpl restrains MIR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia 75
UCbase & miRfunc: a database of ultraconservedsequences and microRNA function 74
PDGFRA is controlled by miRNAs in head and neck paraganglioma cells: in vitro and in vivo treatment with imatinib mesylate. 74
E2F1 activation is responsible for pituitary adenomas induced byHMGA2 gene overexpression 72
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas 72
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 72
Karyotype-specific microRNA signature in chronic lymphocytic leukemia. 70
Critical Role of the HMGA2 Gene in Pituitary Adenomas 70
Deregulation of microRNA expression infollicular cell-derived human thyroidcarcinomas 70
A microRNA expression signature of humansolid tumors defines cancer gene targets 67
Genechip Microarray analysis of pituitary adenomas developed by HMGA transgenic mice 66
B-RAF mutations are a rare event in pituitary adenomas. 65
The glucose-regulated MiR-483-3p influences key signaling pathways in cancer 65
Mutated β-catenin evades a microRNA-dependentregulatory loop 64
Ucbase and miRfunc: A database which links ultraconserved sequences and microRNA with cancer and mendelian inheritance human disorders 61
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 61
Targeted Disruption of the Murine Homeodomain-InteractingProtein Kinase-2 Causes Growth Deficiency In Vivoand Cell Cycle Arrest In Vitro 60
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas 60
Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice 59
Therapeutic effect of microRNA-15/16 cluster in a mouse model of chronic lymphocytic leukemia 59
HMGA Proteins Up-regulate CCNB2 Gene in Mouse and HumanPituitary Adenomas 58
Regulation of microRNA expression by HMGA1 proteins 57
MiR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 57
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 57
Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophyand Myelo-Lymphoproliferative Disorders in Mice 56
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas 56
A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy 56
Identification of microRNA activity by Targets’ ReverseEXpression 55
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 55
Critical role of the RB-E2F pathway in the generation of pituitary adenomas in transgenic mice overexpressing the HMGA2 gene 54
MiR-181b: New perspective to evaluate disease progression in chronic lymphocytic leukemia 52
Overexpression of the HMGA2 gene induces mixed growth hormone cell/prolactin cell pituitary adenomas by impairment of the RB/E2F pathway 50
Overexpression of the HMGA2 gene induces mixed growth hormon cell/prolactin cell pituitary adenomas by impairment of the Rb/E2F pathway 50
Targeted disruption of the murine PATZ gene induces growth retardation 50
miR-483-3p is an oncogene involved in nephroblastoma and in adult tumors with activated ß-catenin 50
Generation of vectors that coexpress intronic microRNAs and exonic reporters 50
MicroRNAs in autoimmunity and hematological malignancies 50
The Mia/Cd-rap gene expression isdownregulated by the high-mobility group Aproteins in mouse pituitary adenomas 49
Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin 49
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2) 47
Genechip microarray analysis of pituitary adenomas developed by HMG transgenic mice. 47
MiR-181b expression levels decrease during the progression of Chronic Lymphocytic Leukemia: a new potential prognostic tool 46
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 46
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 43
A perspective analysis: microRNAs, glucose metabolism, and drug resistance in colon cancer stem cells 42
Totale 4.214
Categoria #
all - tutte 13.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019141 0 0 0 0 0 0 0 0 0 0 2 139
2019/2020949 217 40 16 36 100 82 138 76 50 94 89 11
2020/2021497 75 6 67 7 39 68 12 8 61 76 43 35
2021/2022365 4 11 5 44 25 5 29 45 51 14 32 100
2022/2023892 89 106 56 105 95 171 51 65 99 14 29 12
2023/2024412 20 17 48 14 29 134 102 8 2 14 24 0
Totale 4.214